NEW brochure: Resveratrol and Blood Glucose Control

April 6th, 2018
|

Click to download the new brochure

The Veri-te™ resveratrol team at Evolva are delighted to announce that we have added a new technical brochure on resveratrol and blood glucose to our portfolio.

In clinical studies resveratrol has been found to:

  • significantly lower fasting glucose, insulin and insulin resistance
    in subjects with Type II Diabetes
  • significantly lower systolic, arterial and pulse blood pressure in diabetic
    subjects
  • also benefit the general population
  • support some diabetes-derived conditions such as diabetic retinopathy, neuropathy and nephropathy and foot ulcers